LFSC
LFSC
About F/M Emerald Life Sciences Innovation ETF
LFSC seeks to invest in innovative life sciences companies that are expected to create value and long-term growth. The actively managed fund relies on a specialized and experienced team to research complex life sciences companies. It invests in US equity securities identified to have growth potential that meet the criteria of technological advancement, market disruption, or artificial...
About F/M Emerald Life Sciences Innovation ETF
LFSC seeks to invest in innovative life sciences companies that are expected to create value and long-term growth. The actively managed fund relies on a specialized and experienced team to research complex life sciences companies. It invests in US equity securities identified to have growth potential that meet the criteria of technological advancement, market disruption, or artificial...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 TVTX | Travere Therapeutics, Inc. | 7.98% | 174.55K | $9.83M |
 SYRE | Spyre Therapeutics, Inc. | 7.13% | 93.64K | $8.78M |
 COGT | Cogent Biosciences, Inc. | 7.03% | 231.23K | $8.66M |
 LIVN | LivaNova PLC | 6.97% | 103.48K | $8.59M |
 GH | Guardant Health, Inc. | 5.88% | 45.70K | $7.24M |
 CORT | Corcept Therapeutics Incorporated | 5.17% | 74.08K | $6.36M |
 MIRM | Mirum Pharmaceuticals, Inc. | 5.03% | 52.05K | $6.20M |
 BLLN | BillionToOne, Inc. | 4.41% | 44.08K | $5.43M |
 CYTK | Cytokinetics, Incorporated | 4.11% | 61.56K | $5.06M |
 UTHR | United Therapeutics Corporation | 3.49% | 8.02K | $4.29M |
 MANE | Veradermics, Incorporated | 3.25% | 36.37K | $4.01M |
 TRVI | Trevi Therapeutics, Inc. | 3.18% | 236.81K | $3.91M |
 SVRA | Savara Inc. | 3.10% | 665.66K | $3.82M |
 NKTR | Nektar Therapeutics | 2.89% | 52.02K | $3.55M |
 DNTH | Dianthus Therapeutics, Inc. | 2.86% | 35.67K | $3.52M |
 TMDX | TransMedics Group, Inc. | 2.63% | 42.83K | $3.24M |
 AXSM | Axsome Therapeutics, Inc. | 2.41% | 13.01K | $2.97M |
 ICUI | ICU Medical, Inc. | 2.12% | 16.59K | $2.61M |
 VRDN | Viridian Therapeutics, Inc. | 2.10% | 136.26K | $2.59M |
 PVLA | Palvella Therapeutics, Inc. | 2.09% | 17.64K | $2.58M |
ASSET ALLOCATION BY REGION
United States
United Kingdom
SingaporeASSET ALLOCATION BY REGION
United States United Kingdom SingaporeHoldings (Top 20)
TVTX
Travere Therapeutics, Inc.
SYRE
Spyre Therapeutics, Inc.
COGT
Cogent Biosciences, Inc.
LIVN
LivaNova PLC
GH
Guardant Health, Inc.
CORT
Corcept Therapeutics Incorporated
MIRM
Mirum Pharmaceuticals, Inc.
BLLN
BillionToOne, Inc.
CYTK
Cytokinetics, Incorporated
UTHR
United Therapeutics Corporation
MANE
Veradermics, Incorporated
TRVI
Trevi Therapeutics, Inc.
SVRA
Savara Inc.
NKTR
Nektar Therapeutics
DNTH
Dianthus Therapeutics, Inc.
TMDX
TransMedics Group, Inc.
AXSM
Axsome Therapeutics, Inc.
ICUI
ICU Medical, Inc.
VRDN
Viridian Therapeutics, Inc.
PVLA
Palvella Therapeutics, Inc.